| scholarly article | Q13442814 |
| P2093 | author name string | Alok Agrawal | |
| Bhavya Voleti | |||
| P2860 | cites work | C-reactive protein levels determine systemic nitric oxide bioavailability in patients with coronary artery disease | Q58816300 |
| Pravastatin sodium activates endothelial nitric oxide synthase independent of its cholesterol-lowering actions | Q61053089 | ||
| Tumor necrosis factor (TNF) inhibits interleukin (IL)-1 and/or IL-6 stimulated synthesis of C-reactive protein (CRP) and serum amyloid A (SAA) in primary cultures of human hepatocytes | Q70113244 | ||
| Regulation of human C-reactive protein gene expression by two synergistic IL-6 responsive elements | Q71248695 | ||
| Gut function and immune and inflammatory responses in patients perioperatively fed with supplemented enteral formulas | Q71864016 | ||
| The Rel family member P50 mediates cytokine-induced C-reactive protein expression by a novel mechanism | Q73086261 | ||
| Inducible nitric oxide synthase expression and erythropoietin production in human hepatocellular carcinoma cells | Q73286503 | ||
| Atherosclerosis and nitric oxide production | Q74302967 | ||
| C-reactive protein and atherosclerosis | Q74526617 | ||
| Interleukin-4 (IL-4) and IL-13 enhance the effect of IL-1beta on production of IL-1 receptor antagonist by human primary hepatocytes and hepatoma HepG2 cells: differential effect on C-reactive protein production | Q78015787 | ||
| CRP or not CRP? That is the question | Q81796168 | ||
| Potential cardioprotective actions of no-releasing aspirin | Q28193422 | ||
| Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids | Q29616817 | ||
| A phase I trial of recombinant human interleukin-11 (neumega rhIL-11 growth factor) in women with breast cancer receiving chemotherapy. | Q33495561 | ||
| Nitric oxide donors | Q34084629 | ||
| Nitric oxide and the regulation of gene expression | Q34134480 | ||
| Chronic treatment with nitric oxide-releasing aspirin reduces plasma low-density lipoprotein oxidation and oxidative stress, arterial oxidation-specific epitopes, and atherogenesis in hypercholesterolemic mice | Q34156437 | ||
| C-reactive protein binds to both oxidized LDL and apoptotic cells through recognition of a common ligand: Phosphorylcholine of oxidized phospholipids | Q34191416 | ||
| Novel effects of nitric oxide | Q34192694 | ||
| C-reactive Protein | Q34344434 | ||
| Inflammation and atherosclerosis: role of C-reactive protein in risk assessment | Q35721270 | ||
| Cytokines, endotoxin, and glucocorticoids regulate the expression of inducible nitric oxide synthase in hepatocytes | Q36058863 | ||
| CRP after 2004. | Q36097479 | ||
| Control of the acute phase response. Demonstration of C-reactive protein synthesis and secretion by hepatocytes during acute inflammation in the rabbit | Q36341777 | ||
| Hepatocytes produce nitrogen oxides from L-arginine in response to inflammatory products of Kupffer cells | Q36356942 | ||
| Interaction of calcium-bound C-reactive protein with fibronectin is controlled by pH: in vivo implications | Q37285802 | ||
| Transactivation of C-reactive protein by IL-6 requires synergistic interaction of CCAAT/enhancer binding protein beta (C/EBP beta) and Rel p50. | Q38304690 | ||
| Transcription factor c-Rel enhances C-reactive protein expression by facilitating the binding of C/EBPβ to the promoter | Q38349770 | ||
| STAT3 participates in transcriptional activation of the C-reactive protein gene by interleukin-6. | Q38358871 | ||
| Statins reduce interleukin-6-induced C-reactive protein in human hepatocytes: new evidence for direct antiinflammatory effects of statins. | Q40442526 | ||
| Evidence for anti-inflammatory activity of statins and PPARalpha activators in human C-reactive protein transgenic mice in vivo and in cultured human hepatocytes in vitro | Q40530232 | ||
| Effect of combinations of cytokines and hormones on synthesis of serum amyloid A and C-reactive protein in Hep 3B cells | Q41669884 | ||
| Regulation of cytokine-induced human C-reactive protein production by transforming growth factor-beta. | Q41718181 | ||
| The effect of interleukin-1 on C-reactive protein expression in Hep3B cells is exerted at the transcriptional level | Q41915919 | ||
| Endothelial dysfunction as a possible link between C-reactive protein levels and cardiovascular disease | Q42487208 | ||
| Statins and the acute-phase response | Q43656475 | ||
| L-arginine rescues decreased erythropoietin gene expression by stimulating GATA-2 with L-NMMA. | Q43889511 | ||
| A C-reactive protein mutant that does not bind to phosphocholine and pneumococcal C-polysaccharide | Q44129524 | ||
| Fibrates down-regulate IL-1-stimulated C-reactive protein gene expression in hepatocytes by reducing nuclear p50-NFkappa B-C/EBP-beta complex formation | Q44189684 | ||
| Global suppression of IL-6-induced acute phase response gene expression after chronic in vivo treatment with the peroxisome proliferator-activated receptor-alpha activator fenofibrate | Q44756924 | ||
| Possible protective role for C-reactive protein in atherogenesis: complement activation by modified lipoproteins halts before detrimental terminal sequence | Q44810016 | ||
| Acute activation and phosphorylation of endothelial nitric oxide synthase by HMG-CoA reductase inhibitors | Q44846597 | ||
| AMPK activation may suppress hepatic production of C-reactive protein by stimulating nitric oxide synthase | Q44965955 | ||
| Effect of low dose atorvastatin versus diet-induced cholesterol lowering on atherosclerotic lesion progression and inflammation in apolipoprotein E*3-Leiden transgenic mice. | Q45130042 | ||
| C-reactive protein levels and outcomes after statin therapy | Q45213511 | ||
| Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease | Q45213515 | ||
| Overexpressed nuclear factor-kappaB can participate in endogenous C-reactive protein induction, and enhances the effects of C/EBPbeta and signal transducer and activator of transcription-3. | Q48003020 | ||
| Acute-phase response of human hepatocytes: Regulation of acute-phase protein synthesis by interleukin-6 | Q58681737 | ||
| P433 | issue | 7 | |
| P921 | main subject | inflammation | Q101991 |
| P304 | page(s) | 891-896 | |
| P577 | publication date | 2005-07-28 | |
| P1433 | published in | Molecular Immunology | Q6895954 |
| P1476 | title | Statins and nitric oxide reduce C-reactive protein production while inflammatory conditions persist | |
| P478 | volume | 43 |
| Q37319289 | A novel RBP-J kappa-dependent switch from C/EBP beta to C/EBP zeta at the C/EBP binding site on the C-reactive protein promoter |
| Q45188488 | Association between telomere length and C-reactive protein and the development of coronary collateral circulation in patients with coronary artery disease |
| Q24321501 | C-reactive protein-bound enzymatically modified low-density lipoprotein does not transform macrophages into foam cells |
| Q36686462 | Comparison of anti-inflammatory effects and high-density lipoprotein cholesterol levels between therapy with quadruple-dose rosuvastatin and rosuvastatin combined with ezetimibe |
| Q61805448 | Crataegus Aronia protects and reverses vascular inflammation in a high fat diet rat model by an antioxidant mechanism and modulating serum levels of oxidized low-density lipoprotein |
| Q55303250 | Dissociation of C-Reactive Protein Localizes and Amplifies Inflammation: Evidence for a Direct Biological Role of C-Reactive Protein and Its Conformational Changes. |
| Q42484896 | Effect of the Combination of Ezetimibe and Simvastatin on Gluconeogenesis and Oxygen Consumption in the Rat Liver |
| Q33699620 | Effect of wine phenolics on cytokine-induced C-reactive protein expression |
| Q57607566 | Effects of Simvastatin on Proinflammatory Cytokines and Matrix Metalloproteinases in Hypercholesterolemic Individuals |
| Q37202135 | Efficacy, effectiveness and real life goal attainment of statins in managing cardiovascular risk |
| Q92405017 | Functionality of C-Reactive Protein for Atheroprotection |
| Q36106594 | Oct-1 acts as a transcriptional repressor on the C-reactive protein promoter |
| Q36008865 | Pattern recognition by pentraxins |
| Q36801469 | Phosphoethanolamine-complexed C-reactive protein: a pharmacological-like macromolecule that binds to native low-density lipoprotein in human serum |
| Q39420246 | Statins cause profound effects on gene expression in human cancer cells in vitro: the role of membrane microdomains. |
| Q43078030 | Systemic inflammation, metabolic syndrome and progressive renal disease |
| Q26999377 | Targeting C-Reactive Protein in Inflammatory Disease by Preventing Conformational Changes |
| Q35999439 | The connection between C-reactive protein and atherosclerosis |
| Q37406470 | Therapeutic potential of phosphoethanolamine-bound C-reactive protein in atherosclerosis |
Search more.